S. Nordqvist Kleppe

Human Papillomavirus Infection Determines Prognosis in Cervical Cancer

P. Sparén, J. Dillner, C. Eklund, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program

P. Sparén, J. Dillner, A. Ploner, 2019, International journal of cancer.

Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment

P. Sparén, J. Dillner, C. Eklund, 2021, AIDS.

HPV Types in Cervical Precancer by HIV Status and Birth Region: A Population-Based Register Study

P. Sparén, J. Dillner, A. Sönnerborg, 2020, Cancer Epidemiology, Biomarkers & Prevention.

SARS‐CoV‐2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden

J. Dillner, S. Hober, L. Engstrand, 2021, Journal of internal medicine.

Viruses in case series of tumors: Consistent presence in different cancers in the same subject

Maria Hortlund, Joakim Dillner, Davit Bzhalava, 2017, PloS one.

Viruses in cancers among the immunosuppressed

Maria Hortlund, J. Dillner, D. Bzhalava, 2017, International journal of cancer.

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

P. Sparén, J. Dillner, C. Eklund, 2020, British Journal of Cancer.

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study

P. Sparén, J. Dillner, A. Ploner, 2019, BMJ.

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study

P. Sparén, J. Dillner, A. Ploner, 2018, PLoS medicine.

High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019

C. Koro, K. Sundström, C. Velicer, 2023, Preventive medicine reports.